Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP1941 in Japanese Patients With Type 1 Diabetes Mellitus
NCT02529449Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ipragliflozin in type 1 diabetes mellitus (T1D), sponsored by Astellas Pharma. Started Sep 2015; status: completed.
02
Drugs
ipragliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02529449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02529449.